33 research outputs found
Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children
The significance of low PU.1 expression in patients with acute promyelocytic leukemia
Abstract Background Although the importance of the hematopoietic transcription factor PU.1 in acute myeloid leukemia (AML) has been demonstrated, the expression of PU.1 in acute promyelocytic leukemia (APL) patient samples awaits further investigation. The current study used APL patient samples to assess the expression pattern of PU.1 in the initiation and progression of APL. Findings We used real-time RT-PCR to compare PU.1 expression between de novo APL patient samples and normal blood specimens, and the results indicated that PU.1 expression was significantly lower in newly diagnosed APL patient samples as compared to normal hematopoietic cells. Further evidence showed a significant inverse correlation between the expression level of PML-RARĪ± and that of PU.1. In addition, we analyzed the correlation between PML-RARĪ± and PU.1 expression in a large population of AML patients retrieved from the expression profiles. The results showed that PU.1 expression was lower in patients with APL than other AML subtypes and there was also a trend towards increasing PU.1 expression from AML-M0 to AML-M5, with the exception of AML-M3 (APL). These observations suggested that PU.1 expression was reduced by PML-RARĪ± in APL patients. Furthermore, we measured PU.1 expression in APL-initiating cells isolated from de novo APL patients by side population cell analysis and found that suppression of PU.1 expression occurred concurrently with PML-RARĪ± expression, indicating the pivotal role of PU.1 in APL initiation. Conclusion Our findings provide evidence that low PU.1 expression in APL patients is required for disease initiation and progression.</p
Growth-Controlled Engineering of Magnetic Exchange Interactions in Single Crystalline GaCoZnO1-v Epitaxial Films with High Co Concentration
While semiconductor spintronics promises lower switching energy and faster speed, a major limitation on its development as a viable technology is the lack of room temperature ferromagnetic semiconductor materials. The material challenge is great, because not only magnetic and electronic doping but also thermally robust coupling between them are required for a room temperature ferromagnetic semiconductor. Here, we report the growth-controlled engineering of magnetic exchange interactions in single crystalline GaCoZnO1-v epitaxial films with high Co concentrations (0.3 ā¤ x ā¤ 0.45) by controlling oxygen vacancy and carrier density through Ga3+ doping. Strong ferromagnetism, spin-split impurity states, and spin-polarized electrical transport are realized and well controlled at room temperature by tailoring the s,p-d exchange coupling. This room temperature ferromagnetic semiconductor, which offers the ability to individually control carrier density and magnetic doping, will lay a solid foundation for the development of practical spintronic devices operating at room temperature
Prevalence and clinical characteristics of atrial fibrillation in hospitalized patients with coronary artery disease and hypertension: a cross-sectional study from 2008 to 2018
Abstract. Background:. The clinical characteristics of patients with the comorbidities of hypertension and coronary artery disease (HT-CAD) and atrial fibrillation (AF) are largely unknown. This study aimed to investigate the prevalence of AF in patients with HT-CAD and clinical characteristics of patients with both HT-CAD and AF.
Methods:. This cross-sectional study was conducted in Chinese People's Liberation Army General Hospital in Beijing, China, and included 20,747 inpatients with HT-CAD with or without AF from August 2008 to July 2018. We examined the overall prevalence, clinical characteristics, comorbidity profiles, treatment patterns, and blood pressure (BP) control of patients with both HT-CAD and AF. Multivariate logistic regression was used to investigate the associations of cardiovascular risk factors with AF in patients with HT-CAD.
Results:. The overall prevalence of AF in patients with HT-CAD was 4.87% (1011/20,747), and this increased with age; to be specific, the prevalence in women and men increased from 0.78% (2/255) and 1.02% (26/2561) at the age of <50 years to 8.73% (193/2210) and 10.28% (298/2900) at the age of ā„70 years, respectively. HT-CAD patients who had AF had a higher prevalence of cardiovascular-related comorbidities than those without AF. Multivariate logistic regression showed that age, gender (male), body mass index, heart failure, and chronic kidney disease were independently associated with the risk of AF in patients with HT-CAD. For those with both HT-CAD and AF, 73.49% (743/1011) had a CHA2DS2-VASc score of ā„4, and only about half of them had the BP controlled at <140/90 mmHg, which indicated a high risk of thromboembolism and stroke. The use of oral anticoagulation increased during the study period (10.00% [20/200] in 2008 to 2011 vs. 30.06% [159/529] in 2015 to 2018, Pā<ā0.01), but remained at a relatively low level.
Conclusions:. AF is highly prevalent among patients with HT-CAD. Patients with both HT-CAD and AF have a higher prevalence of cardiovascular-related comorbidities, lower BP control rate, and lower use of oral anticoagulation
Supplemental data for āAssociation of Resting Heart Rate Trajectories with Cardiovascular Disease and Mortality in Diabetes Mellitus Patientsā
This data is the supplemental data for "Association of Resting Heart Rate Trajectories with Cardiovascular Disease and Mortality in Diabetes Mellitus Patients".Ā </p
Effects of <i>NT5C2</i> Germline Variants on 6-Mecaptopurine Metabolism in Children With Acute Lymphoblastic Leukemia
6-mercaptopurine (6-MP) is widely used in the treatment of acute lymphoblastic leukemia (ALL), and its cytotoxicity is primarily mediated by thioguanine nucleotide metabolites (TGN). Recent genome-wide association study has identified germline polymorphisms (e.g., rs72846714) in the NT5C2 gene associated with 6-MP metabolism in patients with ALL. However, the full spectrum of genetic variation in NT5C2 is unclear and its impact on 6-MP drug activation has not been comprehensively examined. To this end, we performed targeted sequencing of NT5C2 in 588 children with ALL and identified 121 single nucleotide polymorphisms (SNPs) nominally associated with erythrocyte TGN during 6-MP treatment (P < 0.05). Of these, 61 variants were validated in a replication cohort of 372 children with ALL. After considering linkage disequilibrium and multivariate analysis, we confirmed two clusters of variants, represented by rs72846714 and rs58700372, that independently affected 6-MP metabolism. Functional studies showed that rs58700372 directly altered the activity of an intronic enhancer, with the variant allele linked to higher transcription activity and reduced 6-MP metabolism (lower TGN). By contrast, rs72846714 was not located in a regulatory element and instead its association signal was explained by linkage disequilibrium with a proximal functional variant rs12256506 that activated NT5C2 transcription in-cis. Our results indicated that NT5C2 germline variation significantly contributes to inter-patient variability in thiopurine drug disposition
Supplemental data for the article āAssociation of Resting Heart Rate Trajectories with Cardiovascular Disease and Mortality in Diabetes Mellitus Patientsā
This data is the supplemental data for the article "Association of Resting Heart Rate Trajectories with Cardiovascular Disease and Mortality in Diabetes Mellitus Patients".</p